Aldeyra Therapeutics, Inc. (ALDX)
0.7343
+0.07
(+10.40%)
USD |
NASDAQ |
Oct 20, 16:00
0.734
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Gross Profit (TTM) : -0.2661M for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2661M |
| March 31, 2026 | -0.2577M |
| December 31, 2025 | -0.252M |
| September 30, 2025 | -0.2512M |
| June 30, 2025 | -0.2506M |
| March 31, 2025 | -0.2499M |
| December 31, 2024 | -0.2496M |
| September 30, 2024 | -0.2517M |
| June 30, 2024 | -0.2537M |
| March 31, 2024 | -0.2564M |
| December 31, 2023 | -0.2628M |
| September 30, 2023 | -0.263M |
| June 30, 2023 | -0.2633M |
| March 31, 2023 | -0.2629M |
| December 31, 2022 | -0.2587M |
| September 30, 2022 | -0.2533M |
| June 30, 2022 | -0.2564M |
| March 31, 2022 | -0.2591M |
| December 31, 2021 | -0.2642M |
| September 30, 2021 | -0.2029M |
| June 30, 2021 | -0.2077M |
| March 31, 2021 | -0.3577M |
| December 31, 2020 | -0.3619M |
| September 30, 2020 | -0.3859M |
| June 30, 2020 | -0.3368M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1441M |
| December 31, 2019 | -0.0963M |
| September 30, 2019 | -0.0951M |
| June 30, 2019 | -0.09M |
| March 31, 2019 | -0.0838M |
| December 31, 2018 | -0.071M |
| September 30, 2018 | -0.0561M |
| June 30, 2018 | -0.0472M |
| March 31, 2018 | -0.0396M |
| December 31, 2017 | -0.0378M |
| September 30, 2017 | -0.0393M |
| June 30, 2017 | -0.0386M |
| March 31, 2017 | -0.0374M |
| December 31, 2016 | -0.0358M |
| September 30, 2016 | -0.0346M |
| June 30, 2016 | -0.0319M |
| March 31, 2016 | -0.0256M |
| December 31, 2015 | -0.0188M |
| September 30, 2015 | -0.0114M |
| June 30, 2015 | -0.0051M |
| March 31, 2015 | -0.0023M |
| December 31, 2014 | -0.0011M |
| September 30, 2014 | -0.0003M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Prime Medicine, Inc. | -3.325M |
| Arrowhead Pharmaceuticals, Inc. | 643.69M |
| Oncolytics Biotech, Inc. | -0.11M |
| Sangamo Therapeutics, Inc. | 28.00M |
| Sarepta Therapeutics, Inc. | 1.117B |